☆Logos Global Management LP
Quality Q
0.149
AUM ($M)
2,323
Positions
68
Turnover
0.40
Top-10 wt
48%
Herfindahl
0.035
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 88 positions · portfolio value $2,323M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆ERAS funds › | ERASCA INC | ADD | — | 9.6% | +0.3% | 222.6 | 12,150,000 | +1,000,000 | 5 | — |
| ☆ABVX funds › | ABIVAX SA | ADD | — | 5.9% | +2.0% | 136.5 | 1,024,000 | +349,000 | 4 | — |
| ☆RVMD funds › | REVOLUTION MEDICINES INC | TRIM | — | 5.6% | -4.4% | 131.1 | 700,000 | -1,300,000 | 5 | — |
| ☆IDYA funds › | IDEAYA BIOSCIENCES INC | TRIM | — | 4.8% | -1.1% | 111.8 | 3,000,000 | -450,000 | 5 | — |
| ☆BNTX funds › | BIONTECH SE | NEW | — | 4.1% | +4.1% | 94.4 | 1,015,000 | +1,015,000 | 1 | — |
| ☆VERA funds › | VERA THERAPEUTICS INC | NEW | — | 4.1% | +4.1% | 94.4 | 2,200,000 | +2,200,000 | 1 | — |
| ☆TNGX funds › | TANGO THERAPEUTICS INC | TRIM | — | 3.8% | +0.6% | 89.1 | 2,850,000 | -150,000 | 4 | — |
| ☆PRAX funds › | PRAXIS PRECISION MEDICINES I | TRIM | — | 3.7% | -1.0% | 87.0 | 260,000 | -25,000 | 5 | — |
| ☆CLDX funds › | CELLDEX THERAPEUTICS INC NEW | ADD | — | 3.4% | +2.6% | 78.1 | 2,100,000 | +1,650,000 | 3 | — |
| ☆DNTH funds › | DIANTHUS THERAPEUTICS INC | ADD | — | 3.4% | +1.6% | 78.0 | 800,000 | +400,000 | 4 | — |
| ☆CGON funds › | CG ONCOLOGY INC | ADD | — | 3.1% | +1.1% | 71.0 | 1,000,000 | +425,000 | 3 | — |
| ☆IRON funds › | DISC MEDICINE INC | ADD | — | 2.8% | +0.9% | 64.0 | 875,000 | +315,000 | 5 | — |
| ☆MAZE funds › | MAZE THERAPEUTICS INC | ADD | — | 2.5% | +0.6% | 57.7 | 1,935,000 | +700,000 | 5 | — |
| ☆DYN funds › | DYNE THERAPEUTICS INC | ADD | — | 2.4% | +1.1% | 56.6 | 2,550,000 | +1,150,000 | 5 | — |
| ☆MLTX funds › | MOONLAKE IMMUNOTHERAPEUTICS | ADD | — | 2.2% | +0.8% | 52.1 | 2,675,000 | +1,175,000 | 3 | — |
| ☆OCUL funds › | OCULAR THERAPEUTIX INC | ADD | — | 2.2% | +0.6% | 52.0 | 5,300,000 | +1,450,000 | 5 | — |
| ☆DSGN funds › | DESIGN THERAPEUTICS INC | ADD | — | 1.9% | +0.8% | 43.4 | 3,000,000 | +1,050,000 | 5 | — |
| ☆OLMA funds › | OLEMA PHARMACEUTICALS INC | HOLD | — | 1.7% | -0.7% | 40.1 | 3,208,875 | +0 | 5 | — |
| ☆BLTE funds › | BELITE BIO INC | NEW | — | 1.7% | +1.7% | 38.5 | 250,000 | +250,000 | 1 | — |
| ☆ACHV funds › | ACHIEVE LIFE SCIENCE INC | NEW | — | 1.5% | +1.5% | 35.4 | 5,425,000 | +5,425,000 | 1 | — |
| ☆TRVI funds › | TREVI THERAPEUTICS INC | TRIM | — | 1.5% | +0.0% | 35.1 | 1,880,000 | -520,000 | 5 | — |
| ☆COGT funds › | COGENT BIOSCIENCES INC | NEW | — | 1.5% | +1.5% | 34.8 | 900,000 | +900,000 | 1 | — |
| ☆AVBP funds › | ARRIVENT BIOPHARMA INC | ADD | — | 1.5% | +1.1% | 34.7 | 1,000,000 | +650,000 | 2 | — |
| ☆CBIO funds › | CRESCENT BIOPHARMA INC. | ADD | — | 1.5% | +1.0% | 34.2 | 1,900,000 | +1,417,500 | 5 | — |
| ☆CMPS funds › | COMPASS PATHWAYS PLC | NEW | — | 1.4% | +1.4% | 31.8 | 2,250,000 | +2,250,000 | 1 | — |
| ☆MLYS funds › | MINERALYS THERAPEUTICS INC | NEW | — | 1.2% | +1.2% | 28.3 | 1,050,000 | +1,050,000 | 1 | — |
| ☆REPL funds › | REPLIMUNE GROUP INC | NEW | — | 1.2% | +1.2% | 27.7 | 2,500,000 | +2,500,000 | 1 | — |
| ☆XENE funds › | XENON PHARMACEUTICALS INC | HOLD | — | 1.2% | -0.2% | 27.2 | 450,000 | +0 | 2 | — |
| ☆GPCR funds › | STRUCTURE THERAPEUTICS INC | HOLD | — | 1.2% | -0.1% | 26.8 | 500,000 | +0 | 5 | — |
| ☆IMVT funds › | IMMUNOVANT INC | TRIM | — | 1.1% | -0.3% | 25.6 | 665,000 | -410,000 | 5 | — |
| ☆JBIO funds › | JADE BIOSCIENCES INC | ADD | — | 1.1% | +0.8% | 25.0 | 1,125,000 | +725,000 | 5 | — |
| ☆ELVN funds › | ENLIVEN THERAPEUTICS INC | TRIM | — | 1.0% | -0.1% | 23.6 | 465,000 | -75,000 | 5 | — |
| ☆MANE funds › | VERADERMICS INC | ADD | — | 1.0% | +0.9% | 22.1 | 180,000 | +155,000 | 2 | — |
| ☆AVTX funds › | AVALO THERAPEUTICS INC | ADD | — | 0.9% | +0.7% | 21.3 | 1,150,000 | +850,000 | 2 | — |
| ☆RCUS funds › | ARCUS BIOSCIENCES INC | TRIM | — | 0.9% | -0.5% | 20.0 | 650,000 | -550,000 | 2 | — |
| ☆SMMT funds › | SUMMIT THERAPEUTICS INC | NEW | — | 0.8% | +0.8% | 19.7 | 1,350,000 | +1,350,000 | 1 | — |
| ☆IMCR funds › | IMMUNOCORE HLDGS PLC | TRIM | — | 0.8% | -1.5% | 19.1 | 600,000 | -900,000 | 5 | — |
| ☆LBRX funds › | LB PHARMACEUTICALS INC | TRIM | — | 0.8% | -0.3% | 19.0 | 585,000 | -330,000 | 4 | — |
| ☆NERV funds › | MINERVA NEUROSCIENCES INC | ADD | — | 0.8% | -0.2% | 18.3 | 3,288,777 | +73,777 | 3 | — |
| ☆FTH funds › | FAETH THERAPEUTICS INC | ADD | — | 0.8% | +0.7% | 18.1 | 722,020 | +692,020 | 2 | — |
| ☆CRSP funds › | CRISPR THERAPEUTICS AG | NEW | — | 0.7% | +0.7% | 16.4 | 300,000 | +300,000 | 1 | — |
| ☆DBVT funds › | DBV TECHNOLOGIES S A | NEW | — | 0.6% | +0.6% | 15.0 | 915,000 | +915,000 | 1 | — |
| ☆PBLS funds › | PARABILIS MEDICINES INC | NEW | — | 0.6% | +0.6% | 14.4 | 525,000 | +525,000 | 1 | — |
| ☆RYTM funds › | RHYTHM PHARMACEUTICALS INC | TRIM | — | 0.6% | -1.4% | 13.9 | 125,000 | -325,000 | 5 | — |
| ☆VOR funds › | VOR BIOPHARMA INC | TRIM | — | 0.5% | -0.2% | 12.0 | 650,000 | -100,000 | 3 | — |
| ☆SRRK funds › | SCHOLAR ROCK HLDG CORP | NEW | — | 0.5% | +0.5% | 11.0 | 200,000 | +200,000 | 1 | — |
| ☆IMMX funds › | IMMIX BIOPHARMA INC | TRIM | — | 0.4% | -0.1% | 10.3 | 1,000,000 | -225,000 | 3 | — |
| ☆QTTB funds › | Q32 BIO INC | NEW | — | 0.4% | +0.4% | 10.2 | 800,000 | +800,000 | 1 | — |
| ☆ODTX funds › | ODYSSEY THERAPEUTICS INC | NEW | — | 0.4% | +0.4% | 9.8 | 521,736 | +521,736 | 1 | — |
| ☆ANNX funds › | ANNEXON INC | NEW | — | 0.4% | +0.4% | 8.6 | 1,500,000 | +1,500,000 | 1 | — |
| ☆EDIT funds › | EDITAS MEDICINE INC | NEW | — | 0.3% | +0.3% | 7.2 | 2,222,000 | +2,222,000 | 1 | — |
| ☆RLAY funds › | RELAY THERAPEUTICS INC | TRIM | — | 0.3% | -0.1% | 6.5 | 350,000 | -400,000 | 2 | — |
| ☆ACAD funds › | ACADIA PHARMACEUTICALS INC | TRIM | — | 0.3% | -0.6% | 6.3 | 250,000 | -500,000 | 3 | — |
| ☆AMLX funds › | AMYLYX PHARMACEUTICALS INC | TRIM | — | 0.3% | -0.2% | 6.3 | 350,000 | -350,000 | 4 | — |
| ☆HELP funds › | CYBIN INC | NEW | — | 0.2% | +0.2% | 5.0 | 750,000 | +750,000 | 1 | — |
| ☆OKUR funds › | ONKURE THERAPEUTICS INC | NEW | — | 0.2% | +0.2% | 4.4 | 963,855 | +963,855 | 1 | — |
| ☆TENX funds › | TENAX THERAPEUTICS INC | TRIM | — | 0.2% | -0.3% | 4.4 | 300,000 | -325,000 | 2 | — |
| ☆DFTX funds › | DEFINIUM THERAPEUTICS INC | NEW | — | 0.2% | +0.2% | 3.8 | 80,000 | +80,000 | 1 | — |
| ☆UNCY funds › | UNICYCIVE THERAPEUTICS INC | HOLD | — | 0.1% | -0.1% | 2.2 | 473,563 | +0 | 5 | — |
| ☆PTN funds › | PALATIN TECHNOLOGIES INC | TRIM | — | 0.1% | -0.1% | 1.4 | 130,000 | -10,000 | 3 | — |
| ☆QURE funds › | UNIQURE NV | NEW | — | 0.1% | +0.1% | 1.4 | 30,000 | +30,000 | 1 | — |
| ☆JATT funds › | JATT II ACQUISITION CORP | NEW | — | 0.0% | +0.0% | 1.1 | 100,000 | +100,000 | 1 | — |
| ☆RACC funds › | RESEARCH ALLIANCE CORP III | NEW | — | 0.0% | +0.0% | 1.1 | 100,000 | +100,000 | 1 | — |
| ☆ACRS funds › | ACLARIS THERAPEUTICS INC | TRIM | — | 0.0% | -0.1% | 1.1 | 200,000 | -300,000 | 5 | — |
| ☆LGVN funds › | LONGEVERON INC | NEW | — | 0.0% | +0.0% | 0.9 | 1,287,000 | +1,287,000 | 1 | — |
| ☆CUSIP:35168W103 funds › | FRACTYL HEALTH INC | HOLD | — | 0.0% | +0.0% | 0.8 | 1,000,000 | +0 | 4 | — |
| ☆SEPN funds › | SEPTERNA INC | HOLD | — | 0.0% | +0.0% | 0.8 | 23,548 | +0 | 5 | — |
| ☆AMAN funds › | AMANAT ACQUISITION CORP | NEW | — | 0.0% | +0.0% | 0.5 | 50,000 | +50,000 | 1 | — |
| ☆CUSIP:152309100 funds › | CENTESSA PHARMACEUTICALS PLC | EXIT | — | 0.0% | -4.3% | 0.0 | 0 | -2,125,000 | 0 | — |
| ☆CRVS funds › | CORVUS PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -450,000 | 0 | — |
| ☆ORIC funds › | ORIC PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.6% | 0.0 | 0 | -950,000 | 0 | — |
| ☆CMPX funds › | COMPASS THERAPEUTICS INC | EXIT | — | 0.0% | -0.9% | 0.0 | 0 | -3,150,000 | 0 | — |
| ☆NAMS funds › | NEWAMSTERDAM PHARMA COMPANY | EXIT | — | 0.0% | -1.0% | 0.0 | 0 | -600,000 | 0 | — |
| ☆PCVX funds › | VAXCYTE INC | EXIT | — | 0.0% | -0.9% | 0.0 | 0 | -300,000 | 0 | — |
| ☆CYTK funds › | CYTOKINETICS INC | EXIT | — | 0.0% | -3.0% | 0.0 | 0 | -875,000 | 0 | — |
| ☆PHVS funds › | PHARVARIS N V | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -65,000 | 0 | — |
| ☆CUSIP:834203309 funds › | SOLENO THERAPEUTICS INC | EXIT | — | 0.0% | -0.4% | 0.0 | 0 | -250,000 | 0 | — |
| ☆JANX funds › | JANUX THERAPEUTICS INC | EXIT | — | 0.0% | -0.7% | 0.0 | 0 | -1,000,000 | 0 | — |
| ☆VSTM funds › | VERASTEM INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -1,000,000 | 0 | — |
| ☆UTHR funds › | UNITED THERAPEUTICS CORP DEL | EXIT | — | 0.0% | -2.4% | 0.0 | 0 | -80,000 | 0 | — |
| ☆CUSIP:880881107 funds › | TERNS PHARMACEUTICALS INC | EXIT | — | 0.0% | -4.1% | 0.0 | 0 | -1,500,000 | 0 | — |
| ☆MDGL funds › | MADRIGAL PHARMACEUTICALS INC | EXIT | — | 0.0% | -2.3% | 0.0 | 0 | -85,000 | 0 | — |
| ☆BIIB funds › | BIOGEN INC | EXIT | — | 0.0% | -1.9% | 0.0 | 0 | -200,000 | 0 | — |
| ☆IBIO funds › | IBIO INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -1,300,000 | 0 | — |
| ☆MIRM funds › | MIRUM PHARMACEUTICALS INC | EXIT | — | 0.0% | -1.0% | 0.0 | 0 | -200,000 | 0 | — |
| ☆MGTX funds › | MEIRAGTX HLDGS PLC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -700,000 | 0 | — |
| ☆TYRA funds › | TYRA BIOSCIENCES INC | EXIT | — | 0.0% | -1.7% | 0.0 | 0 | -850,000 | 0 | — |
| ☆ALKS funds › | ALKERMES PLC | EXIT | — | 0.0% | -0.6% | 0.0 | 0 | -350,000 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 2,323 | 68 | 0.40 | 48% | 0.035 | 0.149 | — | in |
| 2026Q1 | 1,942 | 63 | 0.32 | 51% | 0.039 | 0.281 | — | in |
| 2025Q4 | 1,501 | 64 | 0.34 | 50% | 0.039 | 0.173 | — | in |
| 2025Q3 | 1,012 | 53 | 0.39 | 45% | 0.034 | 0.082 | — | in |
| 2025Q2 | 749 | 45 | 0.44 | 55% | 0.044 | 0.079 | — | entered |
| 2025Q1 | 563 | 39 | 0.00 | 62% | 0.054 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status